James T England

8PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersHaematological tumoursTransplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biological physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.

Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson

|Feb 06, 2024
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.

James T England, Natasha Szuber, Shireen Sirhan

|Feb 23, 2023
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitor.

James T England, Eshetu G Atenafu, James A Kennedy

|Oct 17, 2022
Fedratinib: a pharmacotherapeutic option for JAK-inhibitor naïve and exposed patients with myelofibrosis.

James T England, Vikas Gupta

|Jul 18, 2022
Osteolytic lesion in polycythemia vera: First report and review of literature.

Verna Cheung, James England, Dawn Maze

|Jul 18, 2022
Hydroxycarbamide-related cutaneous ulcer complicated by osteomyelitis.

James T England, Vikas Gupta

Pageof 2

Frequent Collaborators

5 joint publications

Vikas Gupta

3 joint publications

Dawn Maze

1 joint publications

Verna Cheung

1 joint publications

Benjamin Rolles